FDA Panel Considers EUA for Pfizer COVID-19 Vaccine

Ahead of a vote on the merits of Pfizer’s COVID-19 vaccine, FDA advisers heard experts discuss follow-up and monitoring of the product if it’s cleared on an emergency basis.
Medscape Medical News

Source link